PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Return
33.7%
This Quarter Return
+40.67%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$415M
AUM Growth
+$24.6M
(+6.3%)
Cap. Flow
-$37.8M
Cap. Flow
% of AUM
-9.11%
Top 10 Holdings %
Top 10 Hldgs %
39.8%
Holding
104
New
20
Increased
36
Reduced
26
Closed
21
Top Buys
| 1 |
United Therapeutics
UTHR
|
$12.5M |
| 2 |
Amgen
AMGN
|
$11.2M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$4.08M |
| 4 |
Danaher
DHR
|
$3.89M |
| 5 |
EDAP
EDAP TMS
EDAP
|
$3.73M |
Top Sells
| 1 |
Vericel Corp
VCEL
|
$16.2M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$9.87M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$9.41M |
| 4 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$9.02M |
| 5 |
Schrodinger
SDGR
|
$8.82M |
Sector Composition
| 1 | Healthcare | 95.8% |
| 2 | Technology | 1.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gossamer Bio
GOSS
$571M
| $5.39M | 1.25% |
582,890
+232,111
| +66% | +$2.15M |
|
|
EDAP
27
EDAP TMS
EDAP
$94.2M
| $4.82M | 1.12% |
573,374
+443,485
| +341% | +$3.73M |
|
28
Ionis Pharmaceuticals
IONS
$9.46B
| $4.76M | 1.1% |
105,797
+30,379
| +40% | +$1.37M |
|
29
Arrowhead Research
ARWR
$3.87B
| $4.65M | 1.08% |
70,089
-57,082
| -45% | -$3.79M |
|
30
Madrigal Pharmaceuticals
MDGL
$9.61B
| $4.65M | 1.08% |
39,721
+26,745
| +206% | +$3.13M |
|
31
Sutro Biopharma
STRO
$86.5M
| $4.61M | 1.07% |
202,696
-63,949
| -24% | -$1.46M |
|
32
Stereotaxis
STXS
$251M
| $4.54M | 1.05% |
675,922
+28,379
| +4% | +$191K |
|
33
Axogen
AXGN
$709M
| $4.29M | 1% |
211,599
-18,910
| -8% | -$383K |
|
34
BridgeBio Pharma
BBIO
$9.91B
| $4.02M | 0.93% |
65,174
-10,969
| -14% | -$676K |
|
35
Maravai LifeSciences
MRVI
$341M
| $4.01M | 0.93% |
112,500
+2,224
| +2% | +$79.3K |
|
|
NUAN
36
DELISTED
Nuance Communications, Inc.
NUAN
| $3.98M | 0.92% |
91,173
-24,489
| -21% | -$1.07M |
|
37
Kodiak Sciences
KOD
$452M
| $3.75M | 0.87% |
33,048
-16,865
| -34% | -$1.91M |
|
38
Idexx Laboratories
IDXX
$51.2B
| $3.73M | 0.87% |
7,632
+39
| +0.5% | +$19.1K |
|
39
Outset Medical
OM
$237M
| $3.54M | 0.82% |
4,333
+2,452
| +130% | +$2M |
|
|
SPNE
40
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $3.32M | 0.77% |
190,747
-184,198
| -49% | -$3.21M |
|
|
KDMN
41
DELISTED
Kadmon Holdings, Inc.
KDMN
| $3.21M | 0.74% |
824,475
-109,889
| -12% | -$427K |
|
42
Dentsply Sirona
XRAY
$2.86B
| $3.19M | 0.74% |
+50,000
| New | +$3.19M |
|
|
43
Schrodinger
SDGR
$1.4B
| $3.09M | 0.72% |
40,453
-115,632
| -74% | -$8.82M |
|
44
Health Catalyst
HCAT
$232M
| $3.05M | 0.71% |
65,274
-9,726
| -13% | -$455K |
|
45
Cooper Companies
COO
$13.5B
| $2.88M | 0.67% |
+30,000
| New | +$2.88M |
|
46
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.49M | 0.58% |
244,680
-293,690
| -55% | -$2.99M |
|
47
Jazz Pharmaceuticals
JAZZ
$7.77B
| $2.47M | 0.57% |
+15,000
| New | +$2.47M |
|
48
89bio
ETNB
$1.28B
| $2.42M | 0.56% |
102,163
+5,490
| +6% | +$130K |
|
|
BCEL
49
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $2.33M | 0.54% |
151,993
+25,735
| +20% | +$395K |
|
50
Codexis
CDXS
$218M
| $2.29M | 0.53% |
+100,000
| New | +$2.29M |
|